SERA PROGNOSTICS, INC. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
SERA PROGNOSTICS, INC. (SERA) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $290.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-03-18
- SERA PROGNOSTICS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $290.00K, a 48.12% decline from fiscal 2024.
- SERA PROGNOSTICS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $559.00K, a 20.22% increase from fiscal 2023.
- SERA PROGNOSTICS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $465.00K, a 23.34% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $377.00K, a 28.23% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $290.00K 10-K · filed 2026-03-18 |
| 2024-12-31 | $559.00K 10-K · filed 2026-03-18 |
| 2023-12-31 | $465.00K 10-K · filed 2025-03-19 |
| 2022-12-31 | $377.00K 10-K · filed 2024-03-20 |
| 2021-12-31 | $294.00K 10-K · filed 2023-03-22 |
| 2020-12-31 | $202.00K 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |